Fundraising FoxWave Bye
Denver, US · Founded 2023 · Delaware corporation · 1 known investors
Find your way into Wave Bye
Sign up to see every warm intro you have to Wave Bye
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Wave Bye team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Wave Bye develops non-prescription medications and supplements formulated to reduce period pain, bleeding, and cycle irregularity in women. Its product line includes OBGYN-formulated supplements and an FDA-approved medication for period cramps, sold directly to consumers.
Founders & leadership
Wave Bye was founded in 2023 by Margo Harrison.
MH
Margo HarrisonFounder and CEOMargo Harrison spent 15 years leading clinical teams and 11 years in clinical research strategy and operations, followed by three years in VC-backed consulting before founding Wave Bye, which develops non-prescription medications and supplements to address period pain, bleeding, and cycle irregularity.
Investors · 1
Reported raises · per SEC filings
Form D private placements$852K disclosed across 2 rounds · 2024–2026
▶$800KraisedApr 2026 · 2 investors · Other Health CareRule 506(b)
▶$800KraisedApr 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Margo HarrisonExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $800K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$52KraisedJul 2024 · 15 investors · Other Health CareRule 506(b)
▶$52KraisedJul 2024 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Margo HarrisonExecutive Officer, Director, Promoter
- Offering amount
- $750K
- Amount sold
- $52K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
UbieUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.
ClueClue is a menstrual and reproductive health app that lets people track their periods, cycle, ovulation, fertility, and related symptoms, and contributes anonymized data to scientific research with institutions such as Johns Hopkins and the Gates Foundation. The company offers a paid Clue Plus subscription and serves over 12 million users worldwide.
PerelelPerelel makes doctor-formulated vitamin and supplement packs tailored to specific stages of women's hormonal lives, including trying to conceive, pregnancy trimesters, postpartum, motherhood, and perimenopause. The direct-to-consumer brand sells stage-specific regimens and bundles on a subscription basis.
GlowGlow provides a suite of mobile applications for women's health tracking, including ovulation prediction, pregnancy monitoring, and baby health management. The platform serves women and families seeking to track fertility, prenatal health, and child development, and generates revenue through premium subscriptions and health product sales.
PopsugarPOPSUGAR is a media and lifestyle brand that publishes content covering health, fitness, beauty, lifestyle, shopping, and entertainment for a general consumer audience.
WomenshealthmagWomen's Health is a media brand publishing articles, guides, podcasts, and video series on fitness, nutrition, beauty, and health topics aimed at women. It also offers subscription-based (WH+) workout and nutrition plans covering strength training, muscle building, and longevity.
Companies working in the same space as Wave Bye.
Frequently asked questions
- What does Wave Bye do?
- Wave Bye develops non-prescription medications and supplements formulated to reduce period pain, bleeding, and cycle irregularity in women. Its product line includes OBGYN-formulated supplements and an FDA-approved medication for period cramps, sold directly to consumers.
- Who founded Wave Bye?
- Wave Bye was founded by Margo Harrison in 2023.
- Who are Wave Bye's investors?
- Wave Bye's investors include Colorado BioScience Association.
- How much funding has Wave Bye raised?
- Wave Bye has disclosed $852K raised across 2 rounds.
- Where is Wave Bye headquartered?
- Wave Bye is headquartered in Denver, US.